Showing results (911-920 of 2,404) with videos related to

Sort By:
Pageof 241
Future Medicinal Chemistry|July 7, 2021
Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitorsYongtao Xu, Yunlong Gao, Min Yang, et al.
Future Medicinal Chemistry|July 9, 2021
Structural characteristics of small-molecule inhibitors targeting FTO demethylaseShuting Gao, Xitong Li, Miao Zhang, et al.
Future Medicinal Chemistry|June 2, 2021
Antibacterial properties and carbonic anhydrase inhibition profiles of azido sulfonyl carbamate derivativesPınar Güller, Ufuk Atmaca, Uğur Güller, et al.
Future Medicinal Chemistry|January 8, 2021
Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product databaseJurica Novak, Hrvoje Rimac, Shivananda Kandagalla, et al.
Future Medicinal Chemistry|July 2, 2021
Molecular modeling studies of [4-(3H-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine-based CDK4 inhibitorsHan Lv, Yongli Du, Xiehuang Sheng, et al.
Future Medicinal Chemistry|June 28, 2021
Discovery of novel STAT3 DNA binding domain inhibitorsBocheng Wu, Benny Payero, Sydney Taylor, et al.
Future Medicinal Chemistry|March 27, 2020
Synthesis and evaluation of novel peptidomimetics bearing p-aminobenzoic acid moiety as potential antidiabetic agentsXue-Mei Tang, Wen Hu, Li Fan, et al.
Future Medicinal Chemistry|November 27, 2020
Recent developments of RET protein kinase inhibitors with diverse scaffolds as hinge bindersCong-Cong Jia, Wang Chen, Zi-Li Feng, et al.
Future Medicinal Chemistry|January 5, 2021
Advances in the development of connexin hemichannel inhibitors selective toward Cx43Yagya P Subedi, Guillermo A Altenberg, Cheng-Wei T Chang
Future Medicinal Chemistry|December 4, 2020
Whole blood or plasma: what is the ideal matrix for pharmacokinetic-driven drug candidate selection?Ranjeet P Dash, Vijayabhaskar Veeravalli, Jennifer A Thomas, et al.
Pageof 241